The veteran cardiologist reflects on the meeting’s biggest developments: the new cholesterol guideline, the VITAL trial of vitamin D, the REDUCE-IT controversy and a strikingly potent therapy for lowering Lp(a).
Cleveland Clinic researchers have demonstrated for the first time that lowering blood cholesterol levels could enhance the success of a specific type of T-cell immunotherapy in fighting cancer.
A Cleveland Clinic study reveals a mechanism that rapidly destroys high-density lipoprotein (HDL) in people with Type 2 diabetes, negating cardiovascular protections.
This infographic, derived from an editorial by Dr. Steven Nissen, outlines the causes, effects and high stakes of widespread misinformation about statins and cholesterol.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
A patient’s healthy diet is fundamental to the success of pain management therapies. Here’s how sugar, processed carbohydrates, damaged fats and oils, and toxins can exacerbate chronic pain.
From heart benefits of diabetes drugs to leadless pacing to expanding populations for TAVR, 2016 was a dynamic year in cardiovascular care. Cleveland Clinic experts reflect on a dozen key developments.
FDA’s late-July approval of the first PCSK9 inhibitor is “a major event in cardiovascular medicine,” says Dr. Steve Nissen. Here’s his expert take on the place of this new cholesterol-lowering class in today’s practice.
Two agents in the new PCSK9 inhibitor class just won recommendations for approval from an FDA advisory panel. Here’s why one expert sees them as a breakthrough in how high cholesterol is treated.
For decades, physicians have advised their patients to restrict their intake of high-cholesterol foods to avoid cardiovascular disease. New federal dietary guidelines no longer will limit these foods for most people.
Ability of HDL to remove cholesterol from the blood appears to be more important to cardiovascular risk than the amount of HDL in the blood